Mayo Clinic and King Faisal Specialist Hospital & Research Centre in Saudi Arabia Announce Their New, Integrated Direct Laboratory Interface
The system allows King Faisal Specialist Hospital to seamlessly order Mayo Clinic laboratory tests and receive results in real time.
Mayo Medical Laboratories, the global reference laboratory of Mayo Clinic, and King Faisal Specialist Hospital & Research Centre, with locations in Riyadh and Jeddah, Saudi Arabia, are now electronically linked via the widely used and secure Health Level 7 interface. The system enables King Faisal to order specialized Mayo laboratory tests and receive patient results in real time.
Health Level 7 (commonly referred to as HL7) refers to a set of international standards for transferring health care data between software applications used by the collaborating entities. The interface enhances patient safety and quality of care by expanding the flow of accurate health care information and eliminating manual processes. Mayo Clinic has established more than 500 HL7 interfaces with other health care institutions throughout North America and parts of the world.
“Setting up an HL7 interface represents a major commitment of time and resources,” says William Morice, II, M.D., Ph.D., president of Mayo Medical Laboratories and chair of Mayo Clinic’s Department of Laboratory Medicine and Pathology. “This progressive decision by King Faisal Specialist Hospital supports its commitment—and Mayo’s—to putting the needs of the patient first.”
Now that King Faisal’s laboratory information system (LIS) is securely linked with Mayo Clinic, King Faisal’s staff members may place laboratory orders for Mayo tests, receive results directly into their LIS, and provide their physicians and specialists with real-time information to treat and diagnose patients.
About King Faisal Specialist Hospital & Research Centre
King Faisal Specialist Hospital & Research Centre (KFSH&RC) is a state-of-the-art 1,000+ bed academic medical facility located in Riyadh and Jeddah, Saudi Arabia.
KFSH&RC is the national referral center for oncology, organ transplantation, cardiovascular diseases, neurosciences, and genetic diseases. A full range of tertiary, secondary, and primary health care serves are provided. The hospital’s post-graduate education programs support both residency and fellowship training. The Research Centre focuses on basic and translation research primarily in cancer, cardiovascular diseases, transplant immunology, genetics, molecular diagnostics, and proteomics.
In the Middle East, KFSH&RC has been a pioneer in kidney and bone marrow transplantation, oncology, IVF, and orthopedic and cardiovascular surgery.
The hospital performs more than 2,000 open-heart procedures and 6,500 cardiac catheterizations per year. It offers chemotherapy, radiation therapy, and bone marrow transplants, treating more than 2,800 new adult patients per year. Pediatric oncology/hematology patients are treated in a 40-bed, state-of-the-art facility, the King Fahad National Centre for Children’s Cancer and Research that opened in 1997.